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Events during follow-up
Death Recurrent Ischemia
lower transvalvular pressure gradients little benefit in exercise performance
is achieved with p-blocker therapy in patients with moderately severe mitral
stenosis.
Multivariate analysis identified BBT as an independent predictor of long-
term survival in the t-PA arm, but not the PTCA arm. In PTCA pts, BBT was
a univariate predictor of the combined end point of freedom from death,
infarction, heart failure and dysrhythmias.
Conclusion: BBT appears to provide significant beneficial effects during
long-term follow-up after t-PA for acute MI; these benefits were less impres-
sive and not statistically significant in the PTCA-treated patients.
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The Polish Amiodarone Trial revealed significant reduction of l-year cardiac
mortality with low-dose Amiodarone (Am) after MI. To assess whether this
beneficial effect persisted, the long-term outcomes of the pts of the Am
treated group (n = 305) and ofthe control group (C) (n = 309) were assessed.
The probability of cardiac death after 12 and 46 months according to
Kaplan-Meier curves was respectively Am 6.2,17.4% and C 10.7, 19.5%.
The curves after 12 months remained parallel.
The comparison of 25 pts treated continuosly for 46 months with Am
and 189 C pts not treated with Am revealed significant difference in survival
curves in favour of Am treated group (p = 0.04).
Side effects occurred in 3 of 25 pts treated with Am during long-term
follow-up.
Beneficial effect of one year Am treatment on survival after Mi persists for
the next three years. The prolongation of therapy is feasible and diminishes
the risk of cardiac death.
Long-term Secondary Prevention After
Myocardial Infarction with Amiodarone
We conclude 1) PMC with IN provides better immediate results than DB.
mainly because of a tendency towards less frequent severe MR. 2} Never-
theless, no difference in functional results is apparant at 2 years,
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Comparison of Immediate and Mid-term Results
Following Percutaneous Mitral Commissurotomy
with the Inoue Stepwise Technique and with the
Double-Balloon Technique
Long Term (6 year) Outcome After Catheter
Balloon Valvuloplasty in Patients with Mitral
Stenosis
Increase in VA (2D echo) (cm2)
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Immediate and mid-term results of percutaneous mitral commissurotomy
(PMC) were compared following the use of the Double-Balloon technique
(DB) and the Inoue stepwise technique (IN) under echo-guidance. Between
1986 and 1994, 1228 patients (pts) underwent PMC in our department. 586
pts with DB and, more recently, 642 pts with IN.
Before PMC, no significant difference was found between the two groups
as regards clinical or echocardiographic or hemodynamic data.
Good immediate results were defined as a final valve area (VA) ~1.5 cm2
without mitral regurgitation (MR) >2/4. Good results at 2 years were defined
as survival without operation and with continuing good functional results
INYHA class I or II}.
Results were as follows:
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Beta-Adrenergic Blockade in Patients with
Moderate Mitral Stenosis
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p-blocker therapy remains controversial in patients with mitral stenosis. In
this randomized, double-blinded, crossover, placebo-controlled study, the ef-
fects of atenolol (50 and 100 mglday) were assessed in 15 patients (age =
46 ± 11 yrs) with moderate mitral stenosis (mitral valve area = 1.0 ± 0.4
cm2; NYHA class II-III) at rest (R) and during upright bicycle ergometry IE}.
Doppler-echocardiography was employed to compare heart rate IHR), car-
diac (CI) and stroke volume (SVI) indices, diastolic filling period (DFP), and
peak and mean (Mn Grad) transmitral gradients; a metabolic cart was used
to obtain maximum V02, VC02 and anaerobic threshold (AT). P-blockade
therapy did not improve exercise time, extemal work, max V02 or AT. During
exercise, max V02 and CI decreased (p < 0.05) > 11 % and >20%, respec-
tively, with atenolol. Thefollowing hemodynamic data are presented as mean
±sd:
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Catheter balloon valvuloplasty (CBV) for mitral stenosis was performed in
132 patients (pts) from 1986 to '94. There were 104 women 179%) and 28
men, aged 44 ± 14 years. Pre-CBV, 12 pts were NYHA Functional Class (FC)
IV, 87 in FC III. 28 FC II and 2 were FC I. CBV increased mitral valve area IMVA)
from 0.98 ± 0.26 to 1.94 ± 0.57 cm2, p < 0.001.
There were 6 early deaths up to 1 month ("procedure-related"); all 4 late
deaths occurred after elective valve replacement (VR) was performed 18.2
± 25 months later. Actuarial 6 yr survival was 83 ± 6% when mortality after
VR is included, excluding these 6 yr survival was 95 ± 1%. Actuarial 1, 3 and
6 yr event-free survival (survival without VR or repeat CBV) were 80 ± 4%,
76 ± 4% and 63 ± 7%. Pre-CBV variables were not significant predictors of
outcome. On multivariate analysis, post-CBV independent predictors of 6 yr
event-free survival were 1) MVA ~1.5 vs < 1.5 cm2, 73 ± 8% vs 32 ± 12%; 2}
Pulmonary artery (PA) wedge .:::18 vs > 18 mmHg, 84 ± 6% vs 38 ± 12%, P
< 0.001 for both. Pts. with MVA ~ 1.5 cm2 In = 96) could be further divided
into high and low-risk subgroups for 6 yr event-free survival by 3 post-CBV
variables: 11 PA wedge .:::18 vs > 18, 90 ± 6% vs 46 ± 15% (p = 0.002); 2)
Mean PA <30 vs ~30, 89 ± 6% vs 54 ± 14% (p = 0.061; 3) Cardiac Index (CI)
~2.5 vs <2.5.82 ± 8% vs 53 ± 17% (p = 0.002). Pts with post-CBV MVA
<1.5 In = 24) had no additional predictors of event-free survival. Of those
pts who did not undergo VR or repeat CBV 94% were FCI or FCII.
Conclusions: CBV for mitral stenosis has good long term results up to 6
yrs. Late deaths were related to elective surgery. 6 yr event-free survival was
very good in pts with post-CBV MVA ~1.5 cm2 especially if PA wedge was
.:::18 or CI was ~2.5.
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Placebo Atenolol
50 mg 100 mg
HR R 76 ± 13 60 ± 11' 58 ± 13'
(bpm) E 144 ± 15 112± 23' 103 ± 21'
DFP R 431 ± 97 604 ± 148' 629 ± 175'
1msec) E 208 ± 35 277 ± 90' 300 ± 95'
SVI R 22 ± 7 22 ± 6 26 ± 8
Imllm2) E 21 ± 10 22 ± 10 26 ± 9
Mn Grad R 5 ± 4 4± 3 4± 2
(mmHg) E 20 ± 8 17± 8 15 ± 8'
'p < 0.05 Placebo vs Atenolol
Although HR and Mn Grad decreased and DFP increased with atenolol,
SVI changed little compared with placebo. The data suggest that in spite of
Late Cardiac Catheterization Results of Catheter
Balloon Commissurotomy for Mitral Stenosis at
Rest and Exercise
DaVid Kawanishi, Becky Lopez, Sharon Orrange, Susan Curry,
Shahbudin Rahimtoola. University ofSouthern California. Los Angeles. CA
Cardiac catheterization (cath) was performed on 132 patients (pts) both pre
and immediately post catheter balloon commissurotomy ICBC). Sixty eight
pt's had cath performed at 3--B months post-CBC and twenty had a late
follow-up cath (mean 3.2 yrs. range 1-7 yrs). At late follow-up cath 16 of the
20 pts were NYHA functional class (FC) I or II; 13 females and 3 males age 40
± 11 yrs, We have reviewed the sequential hemodynamic findings in these
16 pt's to see if hemodynamic improvement achieved by CBC is sustained.
